Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.94% | 24.79% | 18.15% | 16.98% | 15.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.94% | 24.79% | 18.15% | 16.98% | 15.77% |
| Cost of Revenue | 21.89% | 41.79% | 26.72% | 26.33% | 26.23% |
| Gross Profit | 23.26% | 19.99% | 15.86% | 14.42% | 12.96% |
| SG&A Expenses | 58.48% | 59.18% | 31.23% | 26.22% | 16.50% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.54% | 41.98% | 34.18% | -7.92% | 4.50% |
| Operating Income | -46.02% | -50.83% | -43.32% | 16.59% | 0.16% |
| Income Before Tax | -63.37% | -26.60% | -38.59% | -22.72% | 1.74% |
| Income Tax Expenses | 54.84% | 26.85% | 86.40% | 58.11% | 21.95% |
| Earnings from Continuing Operations | -63.33% | -26.60% | -38.75% | -22.79% | 1.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.33% | -26.60% | -38.75% | -22.79% | 1.67% |
| EBIT | -46.02% | -50.83% | -43.32% | 16.59% | 0.16% |
| EBITDA | -46.52% | -51.53% | -44.05% | 16.80% | 0.38% |
| EPS Basic | -34.07% | -2.40% | -14.13% | -9.18% | 9.69% |
| Normalized Basic EPS | -15.70% | -18.96% | -12.78% | 24.46% | 8.35% |
| EPS Diluted | -33.96% | -2.40% | -14.19% | -9.16% | 9.53% |
| Normalized Diluted EPS | -15.70% | -18.96% | -12.78% | 24.46% | 8.35% |
| Average Basic Shares Outstanding | 21.83% | 23.63% | 21.57% | 12.47% | 8.87% |
| Average Diluted Shares Outstanding | 21.83% | 23.63% | 21.57% | 12.47% | 8.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |